Tandem Diabetes Care TNDM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$94.55M+48.8% | -$204.71M-112% | -$204.12M-61.0% | -$206.21M-51.1% | -$184.62M-30.5% | ||
| $17.86M+5.8% | $17.67M+6.4% | $17.42M+6.2% | $17.13M+5.7% | $16.88M+3.1% | ||
| $82.55M-21.3% | $92.38M-8.9% | $100.44M+4.7% | $105.58M+16.8% | $104.83M+17.9% | ||
| $1.93M-0.7% | $1.86M-11.0% | $1.92M-7.9% | $1.97M-13.4% | $1.94M-17.3% | ||
| $10.16M+10.3% | $9.48M-5.0% | $9.42M+7.4% | $9.83M+51.2% | $9.21M+45.0% | ||
| $23.29M-43.8% | $56.81M+173% | $26.88M— | $37.17M— | $41.4M— | ||
| -$17.14M-39.9% | -$24.82M-327% | -$17.85M-320% | -$23.03M-224% | -$12.25M-147% | ||
| —— | —— | —— | —— | $7.61M+204% | ||
| —— | —— | —— | —— | —— | ||
| $16.13M+973% | $6.89M+871% | -$4.04M-364% | -$4.32M— | -$1.85M— | ||
| —— | —— | $5.71M— | —— | —— | ||
| —— | —— | —— | —— | $968K+105% | ||
| -$4.27M+88.1% | -$4.79M+86.2% | -$35.25M-547% | -$36.19M-309% | -$35.96M-278% | ||
| -$14.52M-159% | -$14.19M-591% | -$11.69M— | -$8.97M— | -$5.6M— | ||
| $22.12M+1.9% | $19.23M+9.3% | $19.72M— | $22.03M— | $21.71M— | ||
| —— | —— | —— | $9.72M+147% | $13.94M+165% | ||
| $23.25M+31.1% | $19.95M+3.7% | $16.33M-23.5% | $17.48M-18.8% | $17.74M-20.9% | ||
| $292.34M+54.3% | $85.66M-67.6% | $68.95M-81.4% | $113.08M-75.0% | $189.51M-61.0% | ||
| $218.96M-23.9% | $257.07M-16.1% | $268.02M-27.5% | $272.86M-35.5% | $287.88M-38.3% | ||
| $0-100% | $75.22M— | $75.22M— | $75.22M— | $75.22M— | ||
| —— | —— | —— | —— | —— | ||
| $291.16M— | $0— | —— | —— | —— | ||
| $232.88M— | -$45.97M— | -$43.67M— | —— | —— | ||
| $2.42M+1,302% | $1.61M+28.3% | $2.51M— | $881K— | -$201K— | ||
| —— | —— | —— | —— | -$5.41M+92.5% | ||
| —— | $5.06M+63.2% | $6.74M+365% | $6.81M+410% | $4.39M+141% | ||
| $1.93M-0.7% | $1.86M-11.0% | $1.92M-7.9% | $1.97M-13.4% | $1.94M-17.3% | ||
| -$14.52M-159% | -$14.19M-591% | -$11.69M— | -$8.97M— | -$5.6M— | ||
| $4.96M-43.7% | $6M-71.3% | $5.76M-62.4% | $8.67M+10.9% | $8.81M+113% | ||
| $22.12M+1.9% | $19.23M+9.3% | $19.72M— | $22.03M— | $21.71M— | ||
| —— | —— | $5.71M— | —— | —— | ||
| —— | —— | $14.28M— | —— | —— | ||
| $3.43M+12.9% | $3.83M+64.9% | $3.81M+1,959% | $4.45M+304% | $3.04M+207% | ||
| —— | —— | —— | —— | —— | ||
| $10.16M+10.3% | $9.48M-5.0% | $9.42M+7.4% | $9.83M+51.2% | $9.21M+45.0% | ||
| $0-100% | $75.22M— | $75.22M— | $75.22M— | $75.22M— | ||
| —— | —— | —— | —— | $43.46M— | ||
| $292.34M+54.3% | $85.66M-67.6% | $68.95M-81.4% | $113.08M-75.0% | $189.51M-61.0% | ||
| $218.96M-23.9% | $257.07M-16.1% | $268.02M-27.5% | $272.86M-35.5% | $287.88M-38.3% | ||
| —— | —— | —— | —— | $9.74M+769% | ||
| $15.3M— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$4.27M+88.1% | -$4.79M+86.2% | -$35.25M-547% | -$36.19M-309% | -$35.96M-278% | ||
| $22.12M+1.9% | $19.23M+9.3% | $19.72M— | $22.03M— | $21.71M— | ||
| —— | —— | —— | $13.3M— | $0+100% | ||
| $26.2M+526% | $26.17M+462% | $26.17M+462% | $876K-76.8% | $4.19M+82.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$7.76M+81.5% | -$3.8M+91.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tandem Diabetes Care generate?
- Tandem Diabetes Care (TNDM) generated -$6.0M in operating cash flow over the trailing twelve months.
- What is Tandem Diabetes Care's free cash flow?
- After $23.3M of capital expenditures, Tandem Diabetes Care's free cash flow was -$24.5M over the trailing twelve months, down 62.7% year over year.
- Where does Tandem Diabetes Care's cash flow data come from?
- Every line is extracted from Tandem Diabetes Care's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
